- Home
- SIFY vs ARVN Comparison
SIFY vs ARVN Comparison
Compare SIFY & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIFY | ARVN |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 844.3M | 806.0M |
| IPO Year | 1999 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SIFY | ARVN |
|---|---|---|
| Price | $11.09 | $13.00 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 23 |
| Target Price | N/A | ★ $17.80 |
| AVG Volume (30 Days) | 55.4K | ★ 2.3M |
| Earning Date | 01-16-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $466,559,277.00 | $312,300,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $13.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 9.09 | ★ 93.86 |
| 52 Week Low | $2.80 | $5.90 |
| 52 Week High | $17.85 | $25.75 |
Technical Indicators
Market Signals| Indicator | SIFY | ARVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 62.10 |
| Support Level | $10.85 | $11.66 |
| Resistance Level | $12.24 | $13.56 |
| Average True Range (ATR) | 0.64 | 0.58 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 41.86 | 76.36 |
Price Performance
Historical ComparisonAbout SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.